Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Chemical Society Reviews
|
June 14, 2022
Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases
Yunlong Lu, Xiaoyan Ma, Xingyu Chang, et al.
European Journal of Medicinal Chemistry
|
April 5, 2023
Design, synthesis and biological evaluation of fluorinated selective estrogen receptor degraders (FSERDs) --- A promising strategy for advanced ER positive breast cancer
Yunlong Lu, Chao Liu, Xin Wang, et al.
Journal of Medicinal Chemistry
|
January 23, 2024
Simultaneous Activation of Immunogenic Cell Death and cGAS-STING Pathway by Liver- and Mitochondria-Targeted Gold(I) Complexes for Chemoimmunotherapy of Hepatocellular Carcinoma
Fuwei Li, Zhenfan Wen, Chuanxing Wu, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
July 18, 2015
Design, synthesis and preliminary structure-activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives
Haoran Liu, Haoqun Fan, Xiaohui Gao, et al.
Redox Biology
|
June 7, 2022
Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma
Zhongren Xu, Jianqiang Xu, Shibo Sun, et al.
Experimental Hematology & Oncology
|
March 1, 2024
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice
Ling Zhou, Yunlong Lu, Wei Liu, et al.
Pharmacological Research
|
March 18, 2023
SERD-NHC-Au(I) complexes for dual targeting ER and TrxR to induce ICD in breast cancer
Yunlong Lu, Xinyu Sheng, Chao Liu, et al.
Bioorganic Chemistry
|
April 24, 2026
Discovery and development of the preclinical candidate (SH-1092), a potent third generation EGFR inhibitor for the treatment of NSCLC
Kejun Liu, Feiwan Zou, He Zhang, et al.
Journal of Medicinal Chemistry
|
June 10, 2022
Biotin-Targeted Au(I) Radiosensitizer for Cancer Synergistic Therapy by Intervening with Redox Homeostasis and Inducing Ferroptosis
Zhibin Yang, Sheng Huang, Yu Liu, et al.
Redox Biology
|
February 9, 2023
Gold(I) selenium N-heterocyclic carbene complexes as potent antibacterial agents against multidrug-resistant gram-negative bacteria via inhibiting thioredoxin reductase
Xiuli Chen, Shibo Sun, Sheng Huang, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Chemical Society Reviews
|
June 14, 2022
Recent development of gold(I) and gold(III) complexes as therapeutic agents for cancer diseases
Yunlong Lu, Xiaoyan Ma, Xingyu Chang, et al.
European Journal of Medicinal Chemistry
|
April 5, 2023
Design, synthesis and biological evaluation of fluorinated selective estrogen receptor degraders (FSERDs) --- A promising strategy for advanced ER positive breast cancer
Yunlong Lu, Chao Liu, Xin Wang, et al.
Journal of Medicinal Chemistry
|
January 23, 2024
Simultaneous Activation of Immunogenic Cell Death and cGAS-STING Pathway by Liver- and Mitochondria-Targeted Gold(I) Complexes for Chemoimmunotherapy of Hepatocellular Carcinoma
Fuwei Li, Zhenfan Wen, Chuanxing Wu, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
July 18, 2015
Design, synthesis and preliminary structure-activity relationship investigation of nitrogen-containing chalcone derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors: a further study based on Flavokawain B Mannich base derivatives
Haoran Liu, Haoqun Fan, Xiaohui Gao, et al.
Redox Biology
|
June 7, 2022
Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma
Zhongren Xu, Jianqiang Xu, Shibo Sun, et al.
Experimental Hematology & Oncology
|
March 1, 2024
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice
Ling Zhou, Yunlong Lu, Wei Liu, et al.
Pharmacological Research
|
March 18, 2023
SERD-NHC-Au(I) complexes for dual targeting ER and TrxR to induce ICD in breast cancer
Yunlong Lu, Xinyu Sheng, Chao Liu, et al.
Bioorganic Chemistry
|
April 24, 2026
Discovery and development of the preclinical candidate (SH-1092), a potent third generation EGFR inhibitor for the treatment of NSCLC
Kejun Liu, Feiwan Zou, He Zhang, et al.
Journal of Medicinal Chemistry
|
June 10, 2022
Biotin-Targeted Au(I) Radiosensitizer for Cancer Synergistic Therapy by Intervening with Redox Homeostasis and Inducing Ferroptosis
Zhibin Yang, Sheng Huang, Yu Liu, et al.
Redox Biology
|
February 9, 2023
Gold(I) selenium N-heterocyclic carbene complexes as potent antibacterial agents against multidrug-resistant gram-negative bacteria via inhibiting thioredoxin reductase
Xiuli Chen, Shibo Sun, Sheng Huang, et al.
Page
of 8